http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104558047-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0086 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 |
| filingDate | 2014-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104558047-B |
| titleOfInvention | Platinum bis(2-benzoylpyridine)monochloride (II) as well as synthesis method and application thereof |
| abstract | The invention discloses platinum bis(2-benzoylpyridine)monochloride (II) as well as a synthesis method and an application thereof. The synthesis method of the compound comprises the step of dissolving 2-benzoylpyridine and platinum bis(methyl sulfoxide) dichloride into a polar solvent system to have a coordination reaction, thereby obtaining the compound, wherein the polar solvent system is the combination of water and one or two of methanol and ethanol or the combination of dimethyl sulfoxide and one or two of methanol and ethanol. The applicant inspects the proliferation inhibition activity of the compound for a plurality of human tumor cell strains, and results indicate that the compound has remarkable in-vitro antitumor activity and good potential medicinal value, and is expected to be applied to preparation of various antitumor drugs. The chemical structural formula of the platinum bis(2-benzoylpyridine)monochloride (II) is as shown in the specification. |
| priorityDate | 2014-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.